Sanofi (SNY) EV to EBIT (2009 - 2026)
Sanofi's EV to EBIT came in at 12.05 for the quarter ended Jun 30, 2026, up 135.1% from 5.13 a year earlier but down 2.6% from the prior quarter.
Powered by 
Analysis
Sanofi (SNY) EV to EBIT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Sanofi reported EV to EBIT of 5.03, up 112.7% year-over-year; for the year ended Dec 31, 2025, it was 7.09, up 4.5% from the prior year.
- Going back by year, EV to EBIT was 6.78 in the year ended Dec 31, 2024 (-5.1%), 7.15 in the year ended Dec 31, 2023 (+59.4%), 4.48 in the year ended Dec 31, 2022 (-16.7%) and 5.38 in the year ended Dec 31, 2021 (+93.3%).
- The five-year range for quarterly EV to EBIT is 3.44 (the quarter ended Dec 31, 2023) to 12.37 (the quarter ended Mar 31, 2026).
- Year-over-year, EV to EBIT has increased for three consecutive quarters, with growth averaging 60.3% over the last eight quarters.
- The fastest year-over-year change in EV to EBIT over five years came in the quarter ended Jun 30, 2026 (growth of 135.1%), and the weakest in the quarter ended Mar 31, 2024 (a decline of 41.4%).
- Business Quant data shows SNY's EV to EBIT at 12.37 (quarter ended Mar 31, 2026), 12.31 (quarter ended Dec 31, 2025) and 3.70 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.65 Bn | 1,098.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.30 Bn | 555.16 Bn | 17.30 Bn |
| 3 | AbbVie | 504.45 Bn | 477.56 Bn | 12.70 Bn |
| 4 | Merck | 358.32 Bn | 312.70 Bn | 12.21 Bn |
| 5 | Novartis Ag | 290.03 Bn | 254.02 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.08 Bn | 238.77 Bn | 12.86 Bn |
| 7 | Amgen | 237.81 Bn | 193.21 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.88 Bn | 169.07 Bn | 6.22 Bn |
| 9 | Pfizer | 171.37 Bn | 118.01 Bn | 10.94 Bn |
| 10 | Sanofi | 50.60 Bn | 17.12 Bn | 10.79 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.70 |
| Mar 31, 2026 | 7.22 |
| Dec 31, 2025 | 7.09 |
| Sep 30, 2025 | 3.69 |
| Jun 30, 2025 | 5.06 |
| Mar 31, 2025 | 7.18 |
| Dec 31, 2024 | 7.15 |
| Sep 30, 2024 | 11.64 |
| Jun 30, 2024 | 9.27 |
| Mar 31, 2024 | 9.84 |
| Dec 31, 2023 | 7.10 |
| Sep 30, 2023 | 5.48 |
| Jun 30, 2023 | 5.14 |
| Mar 31, 2023 | 6.18 |
| Dec 31, 2022 | 4.29 |
| Sep 30, 2022 | 5.55 |
| Jun 30, 2022 | 5.95 |
| Mar 31, 2022 | 6.62 |
| Dec 31, 2021 | 5.44 |
| Sep 30, 2021 | 6.22 |
API Access
Sanofi EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();